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Abstract
Objective We assessed the efficacy of routine glycated hemoglobin (HbA1c) testing to detect undiagnosed
diabetes and prediabetes in an urban Australian public hospital emergency department (ED) located in an
area of high diabetes prevalence.
Methods Over 6 weeks, all patients undergoing blood sampling in the ED had their random blood glucose
measured. If ≥5.5 mmol/L (99 mg/dL), HbA1c was measured on the same sample. HbA1c levels ≥6.5% (48
mmol/mol) and 5.7–6.4% (39–46 mmol/mol) were diagnostic of diabetes and prediabetes, respectively.
Hospital records were reviewed to identify patients with previously diagnosed diabetes.
Results Among 4580 presentations, 2652 had blood sampled of which 1267 samples had HbA1c measured.
Of these, 487 (38.4%) had diabetes (either HbA1c≥6.5% or a prior diagnosis), and a further 347 (27.4%) had
prediabetes. Among those with diabetes, 32.2% were previously undiagnosed.
Conclusions Routine HbA1c testing in the ED identifies a large number of people with undiagnosed diabetes
and prediabetes, and provides an opportunity to improve their care.
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ABSTRACT
Objective: We assessed the efficacy of routine
glycated hemoglobin (HbA1c) testing to detect
undiagnosed diabetes and prediabetes in an urban
Australian public hospital emergency department (ED)
located in an area of high diabetes prevalence.
Methods: Over 6 weeks, all patients undergoing blood
sampling in the ED had their random blood glucose
measured. If ≥5.5 mmol/L (99 mg/dL), HbA1c was
measured on the same sample. HbA1c levels ≥6.5%
(48 mmol/mol) and 5.7–6.4% (39–46 mmol/mol) were
diagnostic of diabetes and prediabetes, respectively.
Hospital records were reviewed to identify patients with
previously diagnosed diabetes.
Results: Among 4580 presentations, 2652 had blood
sampled of which 1267 samples had HbA1c measured.
Of these, 487 (38.4%) had diabetes (either
HbA1c≥6.5% or a prior diagnosis), and a further 347
(27.4%) had prediabetes. Among those with diabetes,
32.2% were previously undiagnosed.
Conclusions: Routine HbA1c testing in the ED
identifies a large number of people with undiagnosed
diabetes and prediabetes, and provides an opportunity
to improve their care.
INTRODUCTION
Diabetes has traditionally been diagnosed by
the 75 g oral glucose tolerance test (75 g
OGTT), but recent adoption of glycated
hemoglobin (HbA1c) as a diagnostic tool for
high-risk individuals has simplified the diag-
nostic process.1–3 Underdetection remains a
major barrier to prevention of diabetes and
associated complications. Targeted HbA1c
testing of high-risk populations could
enhance the detection of diabetes and pre-
diabetes. The purpose of this study was to
test this hypothesis in patients presenting to
a hospital emergency department (ED).
METHODS
The study was conducted over 6 weeks in the
ED of Blacktown-Mt Druitt Hospital, located in
the western suburbs of Sydney, Australia. This is
an area of high diabetes prevalence.4
Opportunistic blood glucose measurements
were undertaken in all non-pregnant indivi-
duals ≥16 years of age who had blood collected
after presenting to the ED, irrespective of the
presenting problem. HbA1c was automatically
measured if the random glucose was
≥5.5 mmol/L (99 mg/dL). This cut-off level
was chosen based on another Australian ED
study5 and a substudy that we undertook
(unpublished). In this substudy, HbA1c mea-
surements were undertaken in 50 patients pre-
senting through ED with random glucose levels
<5.5 mmol/L (<99 mg/dL). Only three indivi-
duals were noted to have HbA1c levels ≥6.5%
and the glucose cut-off of ≥5.5 mmol/L
(99 mg/dL) was deemed reasonable.
In patients who re-presented within the
study period, HbA1c testing was undertaken
only on the first presentation. As per
American Diabetes Association recommenda-
tions, diabetes was diagnosed if HbA1c≥6.5%
(48 mmol/mol) and prediabetes was diag-
nosed if HbA1c was between 5.7% and 6.4%
(39–46 mmol/mol).1 HbA1c was measured
using a turbidimetric inhibition immuno-
assay on a Siemens Dimension Vista 1500
platform. Coefficient of variation was 2.9%
and 2.4%, at a HbA1c level of 5.7% and
Key messages
▪ We demonstrate that glycated hemoglobin meas-
urement undertaken in the setting of an emer-
gency department is an effective and feasible
means of finding cases of diabetes and predia-
betes particularly in an area known to have a
high prevalence of diabetes.
▪ Approximately a third of patients tested were pre-
viously unaware that they had diabetes.
▪ Earlier detection of prediabetes provides an
opportunity to introduce measures that may
prevent progression to diabetes.
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10.1%, respectively. Demographic data, previous diagno-
sis of diabetes, and coding information were obtained
from the hospital’s database. This study was discussed
with and approved by the Human Research Ethics
Committee of the Western Sydney Local Health District.
RESULTS
There were 4580 presentations to the ED. Using the
methodology described, 1267 HbA1c measurements
were available (figure 1). Female patients accounted for
47.3% of results obtained. Three hundred and seventy-
nine HbA1c tests were not performed due to multiple
presentations, insufficient blood sampling or issues
related to the automation of HbA1c measurement. In
this cohort, diabetes was present in 38.4% (HbA1c≥6.5%
or a prior diagnosis if HbA1c<6.5%; table 1).
Of the patients identified with diabetes, 45.2% were
female and 32.2% (157/487) were newly diagnosed. Of
newly diagnosed patients, 61.8% had mild diabetes
(HbA1c of 6.5–6.9% or 48–52 mmol/mol). Three
hundred and forty-seven (27.4%) of HbA1c sampled
patients had levels consistent with prediabetes (HbA1c
5.7%–6.4% or 39–46 mmol/mol). The sampling proto-
col resulted in HbA1c being measured in 59% (n=751)
of admitted patients, and, of these, diabetes was present
in 42.4%. Analysis of coding information revealed that
28% of admissions who were known to have diabetes
(either by HbA1c assessment or previously noted in the
medical record) were not coded for the diagnosis of dia-
betes. Of this group, 11% were previously known to have
diabetes, 81% were newly diagnosed, and the remaining
8% were coded as impaired glucose regulation.
DISCUSSION
The key finding from this ED study is that almost two in
every five patients tested on available HbA1c samples
had diabetes. This is consistent with other studies that
indicate a high risk of diabetes in Western Sydney’s eth-
nically diverse, low socioeconomic population.4 6
Importantly, one in three patients found to have dia-
betes were previously unaware of their condition.
Additionally, a further 27.4% had prediabetes, meaning
that 65.7% of patients tested with HbA1c had either
diabetes or prediabetes. The use of HbA1c for diabetes
case finding in the ED had a high yield in our patient
population, but these findings may not necessarily be
replicated in locations with a lower prevalence of dia-
betes. In an Australian tertiary referral hospital’s ED in
Melbourne, Jelinek et al7 noted similar rates of dysglyce-
mia but, despite a high diabetes prevalence, the authors
did not find screening a feasible exercise due to their
reliance on a 75 g OGTT to confirm the diagnosis.
Diagnosis of diabetes was not confined to the mild
end of the spectrum—with a severely elevated HbA1c
level (>9% or 75 mmol/mol) seen in 7.3% of the entire
cohort, and in 10.2% of newly diagnosed patients.
Rapidly identifying admitted patients with poor glycemic
control utilizing a test on a single blood sample that
does not require any pretest preparation provides an
ideal opportunity for intervention by hospital diabetes
services. The majority of the newly diagnosed patients
had early stage diabetes with HbA1c levels of 6.5–6.9%
(48–52 mmol/mol), providing the ideal opportunity for
early intervention to take place before the onset of com-
plications. Almost a third of the individuals diagnosed as
having diabetes were not aware of their diagnosis,
reflecting the hidden burden of diabetes in our commu-
nity. This may indicate that current screening practices
in primary care are insufficient and further supports
opportunistic HbA1c testing in individuals presenting to
hospital, a population seemingly enriched with cases of
diabetes. In Australia, universal health insurance
(Medicare) covers the cost of HbA1c testing to diagnose
diabetes in ‘high-risk’ individuals.8 Our data suggest that
a high proportion of patients presenting to ED and
requiring blood collection would meet this definition.
Use of blood glucose alone for diabetes diagnosis is
problematic because of the presence of ‘stress hypergly-
cemia’, a pitfall avoided by use of the HbA1c test.
The use of HbA1c to identify prediabetes is supported
by the American Diabetes Association.1 Progression to
diabetes may be prevented if these individuals were pro-
vided with achievable lifestyle intervention. This has
been shown to be beneficial in prediabetes in several
studies such as the Diabetes Prevention Program9 and
the Finnish Diabetes Prevention Program.10 One such
lifestyle intervention programme in Australia is the gov-
ernment run Get Healthy initiative.11
A novel feature of this study is the use of HbA1c to
diagnose diabetes in a non-primary care setting.
Previous studies have demonstrated that diabetes screen-
ing in an outpatient and a GP setting is feasible.12 The
visit to ED is an opportunity for us to detect diabetes in
individuals who infrequently seek routine medical care,
and who may otherwise go undetected. An earlier ED
study of a tertiary referral hospital in Adelaide, Australia,
noted a prevalence of undiagnosed diabetes of 11%,5
compared with 32.2% in this study. This may be because
of the highly multicultural population in our study, com-
pared with the overwhelmingly Caucasian population of
Adelaide (table 2).
Figure 1 Study profile. ED, emergency department; HbA1c,
glycated hemoglobin.
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For the purpose of funding and performance review,
all clinical data on admitted patients are coded using
the International Classification of Disease codes. In our
cohort, 28% of patients diagnosed with diabetes based
on an elevated HbA1c were not coded as having dia-
betes, leading to an underestimate in the coded data,
and potential underfunding relative to true case com-
plexity. Coding inaccuracies can also result in an over-
estimation of the number of newly diagnosed individuals
as this calculation is dependent on whether they had
previously been coded as having diabetes.
The use of HbA1c to diagnose diabetes has limitations
as any factor affecting the quantity or quality of the
hemoglobin molecule can result in measurement inac-
curacies. This has not been accounted for in our study,
but would tend to result in an underestimate of diabetes
cases. Sampling was only undertaken in individuals who
had blood collected, and this introduces a source of
bias. It could be argued that the pickup rate for diabetes
could be further improved by advocating routine testing
in all individuals presenting to the ED.
Another limitation of using HbA1c to diagnose dia-
betes is the existence of ethnic variability in the meas-
urement that is not explained by glycemic state,
structural abnormalities or quantity of the hemoglobin
molecule.15–17 This is relevant in our multiethnic popu-
lation where the diagnosis of diabetes can be based on a
slight elevation in the HbA1c level. Our study used
glucose level as the initial screening step and this would
have limited the diagnostic inaccuracies that might have
occurred had this not been undertaken.
Diabetes case finding in the ED is justified as there is
a significant population with known and undiagnosed
diabetes. Following the findings of this pilot, it is
intended that routine HbA1c testing will be the norm in
the ED at Blacktown Hospital.
Table 1 Levels of dysglycemia based on glycated hemoglobin (HbA1c) measurements with subset analysis of individuals
newly diagnosed with diabetes
All patients Admitted patients
HbA1c (%)
Status Per cent mmol/mol N Per cent n Per cent
No diabetes <5.7 <39 433 34.2 244 32.5
Prediabetes 5.7–6.4 39–46 347 27.4 188 25.0
*Known diabetes <6.5 <48 81 6.4 66 8.8
Diabetes 6.5–6.9 48–52 138 10.9 80 10.7
7.0–7.9 53–63 117 9.2 76 10.1
8.0–8.9 64–74 58 4.6 43 5.7
≥9.0 ≥75 93 7.3 54 7.2
Total 1267 100 751 100
Subset analysis
New diabetes 6.5–6.9 48–52 97 61.8 52 80
7.0–7.9 53–63 37 23.6 10 15.4
8.0–8.9 64–74 7 4.5 2 3.1
≥9.0 ≥75 16 10.2 1 1.5
Total 157 100 65 100
*Previously diagnosed with diabetes as noted in the medical record.
Table 2 Comparison of the top 10 cultural groups (based on country of birth) between the study population and the
postcodes within which the respective hospitals are located
Study population Postcode 2148 (Sydney)13 Postcode 5041 (Adelaide)14
Population (%) Population (%) Population (%)
Australia 50.1 Australia 53.2 Australia 78.4
India 5.1 Born elsewhere 9.4 UK 4.6
Philippines 4.9 India 7.5 Country of birth not stated 3.7
England 2.8 Country of birth not stated 4.8 Born elsewhere 2.7
Fiji 2.3 Philippines 4.7 Greece 1.3
Sri Lanka 2.0 UK 2.3 India 1.1
Malta 2.0 New Zealand 2.2 China 1.1
New Zealand 1.7 Fiji 2.0 New Zealand 1.0
Italy 1.6 China 1.9 Italy 0.8
Egypt 1.3 Malta 1.1 Germany 0.7
Source: Australian Bureau of Statistics Census (2011) data.
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